Slc12a8 in the lateral hypothalamus maintains energy metabolism and skeletal muscle functions during aging

Cell Rep. 2022 Jul 26;40(4):111131. doi: 10.1016/j.celrep.2022.111131.

Abstract

Sarcopenia and frailty are urgent socio-economic problems worldwide. Here we demonstrate a functional connection between the lateral hypothalamus (LH) and skeletal muscle through Slc12a8, a recently identified nicotinamide mononucleotide transporter, and its relationship to sarcopenia and frailty. Slc12a8-expressing cells are mainly localized in the LH. LH-specific knockdown of Slc12a8 in young mice decreases activity-dependent energy and carbohydrate expenditure and skeletal muscle functions, including muscle mass, muscle force, intramuscular glycolysis, and protein synthesis. LH-specific Slc12a8 knockdown also decreases sympathetic nerve signals at neuromuscular junctions and β2-adrenergic receptors in skeletal muscle, indicating the importance of the LH-sympathetic nerve-β2-adrenergic receptor axis. LH-specific overexpression of Slc12a8 in aged mice significantly ameliorates age-associated decreases in energy expenditure and skeletal muscle functions. Our results highlight an important role of Slc12a8 in the LH for regulation of whole-body metabolism and skeletal muscle functions and provide insights into the pathogenesis of sarcopenia and frailty during aging.

Keywords: CP: Metabolism; CP: Neuroscience; NAD(+); NMN transporter; PDK4; Slc12a8; aging; frailty; lateral hypothalamus; sarcopenia; skeletal muscle; β2-adrenergic receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology
  • Animals
  • Energy Metabolism
  • Frailty* / metabolism
  • Frailty* / pathology
  • Hypothalamic Area, Lateral
  • Mice
  • Muscle, Skeletal / metabolism
  • Sarcopenia* / metabolism